Funded by the National Institute on Drug Abuse, PrEPresent is a study to develop and pilot test a PrEP activation, navigation and support intervention for Black and Latino young men who have sex with men (BYMSM, L-YMSM) in the Los Angeles metro area. These youth not only have the highest annual incidence of HIV but also are the least likely to have ever used PrEP. There is very clear evidence demonstrating that, while YMSM have high levels of knowledge and intentions to use PrEP, few have used PrEP. Our goal is to address known barriers of engagement along the pre-exposure prophylaxis (PrEP) and HIV care continua to change that.
Adapting and using the HealthMPowerment (HMP) platform, PrEPresent will enroll 150 YMSM/Trans/Non-binary youth into the pilot trial and deliver motivational, tailored messages to facilitate goal setting and achievement of PrEP activation milestones.
Principal Investigators: Michele Kipke, PhD; Lisa Hightow-Weidman, MD, MPH
Partners: Children’s Hospital Los Angeles (CHLA); University of Southern California; University of North Carolina at Chapel Hill
Clinical Trials #: NCT05281393
